Top Markets
Coin of the day
Chr. Hansen Holding A/S Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

CHR
Hisse Senetlerindeki Sıralama #1931
Chr. Hansen Holding A/S is a prominent bioscience firm that develops natural... Chr. Hansen Holding A/S is a prominent bioscience firm that develops natural ingredient solutions for a diverse global market, including the food, nutritional, pharmaceutical, and agricultural sectors across Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company's operations are divided into two main segments: Food Cultures & Enzymes, and Health & Nutrition. The Food Cultures & Enzymes division provides a variety of cultures, enzymes, and probiotic products crucial for enhancing the taste, flavor, texture, longevity, nutritional content, and health advantages of consumer goods, primarily within the dairy industry. Concurrently, the Health & Nutrition segment manufactures and distributes products catering to the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. Additionally, Chr. Hansen has forged a strategic partnership with UPL Ltd. to jointly create and commercialize microbial bio-solutions that promote sustainable agriculture. Founded in 1843, the company's corporate headquarters are located in Hørsholm, Denmark.
Hisse Fiyatı
$87.26
Son senkronizasyon: 2024-01-30
Piyasa Değeri
$11.48B
Değişim (1 gün)
8.58%
Değişim (1 yıl)
0.00%
Ülke
DK
Ticaret Chr. Hansen Holding A/S (CHR)
Chr. Hansen Holding A/S (CHR) için kazanç
2026 itibarıyla kazanç TTM: 0
Chr. Hansen Holding A/S şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Chr. Hansen Holding A/S için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$9.38B -
GB
- -
FR
$3.49B -
US
$2.63B -
US
$-82.10M -
US